For instance, although Lp-PLA2 effectively reflects AS burden, it has limited value in predicting HF risk; conversely, NT-proBNP is highly specific for HF diagnosis but cannot predict the progression to HF in AS patients. This evidence concerns the gene NPPB and hydrops fetalis.